Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Meads

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Trials|October 24, 2025
How should overall survival be analysed in randomised clinical trials in cancer if participants receive subsequent treatment lines? A stakeholder consultationKara-Louise Royle, Peter Wheatstone, David Meads, et al.
BMC Palliative Care|September 25, 2020
Supporting patient access to medicines in community palliative care: on-line survey of health professionals' practice, perceived effectiveness and influencing factorsSue Latter, Natasha Campling, Jacqueline Birtwistle, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2023
UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study ProtocolDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 26, 2026
A UK value set for the EQ-5D-5LDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Social Science & Medicine (1982)|August 15, 2022
Assessing the comparative feasibility, acceptability and equivalence of videoconference interviews and face-to-face interviews using the time trade-off techniqueDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
An International Comparison of EQ-5D-5L and EQ-5D-3L for Use in Cost-Effectiveness AnalysisAllan Wailoo, Mónica Hernández Alava, Stephen Pudney, et al.
Applied Health Economics and Health Policy|April 30, 2025
Evaluating Access Improving Interventions: An Economic Evaluation of Surgical Task-Shifting for C-Sections in Sierra LeoneBryony Dawkins, Bethany Shinkins, Tim Ensor, et al.
BMJ Open|January 13, 2018
A qualitative study of patients' feedback about Outpatient Parenteral Antimicrobial Therapy (OPAT) services in Northern England: implications for service improvementMaureen Twiddy, Carolyn J Czoski Murray, Samantha J Mason, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 24, 2020
UK General Population Utility Values for the SIDECAR-D Instrument Measuring the Impact of Caring for People With DementiaEdward J D Webb, David Meads, Hareth Al-Janabi, et al.
British Journal of Cancer|November 6, 2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): cost-effectiveness and budget impact analysisPaola Cocco, Chris Bojke, Claire Hulme, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Trials|October 24, 2025
How should overall survival be analysed in randomised clinical trials in cancer if participants receive subsequent treatment lines? A stakeholder consultationKara-Louise Royle, Peter Wheatstone, David Meads, et al.
BMC Palliative Care|September 25, 2020
Supporting patient access to medicines in community palliative care: on-line survey of health professionals' practice, perceived effectiveness and influencing factorsSue Latter, Natasha Campling, Jacqueline Birtwistle, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2023
UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study ProtocolDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 26, 2026
A UK value set for the EQ-5D-5LDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Social Science & Medicine (1982)|August 15, 2022
Assessing the comparative feasibility, acceptability and equivalence of videoconference interviews and face-to-face interviews using the time trade-off techniqueDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
An International Comparison of EQ-5D-5L and EQ-5D-3L for Use in Cost-Effectiveness AnalysisAllan Wailoo, Mónica Hernández Alava, Stephen Pudney, et al.
Applied Health Economics and Health Policy|April 30, 2025
Evaluating Access Improving Interventions: An Economic Evaluation of Surgical Task-Shifting for C-Sections in Sierra LeoneBryony Dawkins, Bethany Shinkins, Tim Ensor, et al.
BMJ Open|January 13, 2018
A qualitative study of patients' feedback about Outpatient Parenteral Antimicrobial Therapy (OPAT) services in Northern England: implications for service improvementMaureen Twiddy, Carolyn J Czoski Murray, Samantha J Mason, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 24, 2020
UK General Population Utility Values for the SIDECAR-D Instrument Measuring the Impact of Caring for People With DementiaEdward J D Webb, David Meads, Hareth Al-Janabi, et al.
British Journal of Cancer|November 6, 2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): cost-effectiveness and budget impact analysisPaola Cocco, Chris Bojke, Claire Hulme, et al.
Pageof 10